WT1 and acute myeloid leukemia: Targeted NGS analysis performed at diagnosis and focused on acute myeloid leukemia driver genes is helpful since the presence of pathogenic mutants (IDH1 p.Arg132His, SRSF2 p.Pro95Thr, WT1 p.Cys393Ter in this study) could represent additional risk factors or opportunities for targeted therapy.